Initial studies pointing to how genetic variations can impact disease states such as COVID-19 help to illustrate the growing importance of genomic medicine, writes Mark. J. Stevens.
Mark J. Stevens
Advertisement
Mark J. Stevens is Partner - Life Sciences at Guidehouse.
Articles by Mark J. Stevens
Advertisement
Latest Updated Articles
- COVID-19 and the Evolving Science of Pharmacogenomics
Published: April 28th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
